Does Intra-operative MarginProbe Use Reduce Re-excision Rates?

NACompletedINTERVENTIONAL
Enrollment

127

Participants

Timeline

Start Date

March 22, 2016

Primary Completion Date

December 17, 2019

Study Completion Date

February 16, 2021

Conditions
Breast Cancer
Interventions
DEVICE

MarginProbe

Surgery to take place as per standard care. When the surgery is nearly concluded, patient to be randomised. If randomised to device arm, the MarginProbe device will be used on the outer edge of the tumour and shavings. If the MarginProbe device indicates that cancer is detected, a further shaving is to be taken. Surgery then to be concluded as per standard care.

Trial Locations (1)

M23 9LT

Manchester University NHS Foundation Trust, Manchester

All Listed Sponsors
lead

Manchester University NHS Foundation Trust

OTHER_GOV

NCT02774785 - Does Intra-operative MarginProbe Use Reduce Re-excision Rates? | Biotech Hunter | Biotech Hunter